Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

资助机构

U.S. Department of Health and Human Services

地区

United States

研究领域

Medicine, Oncology

Nursing, Oncology (nursing)

截止日期

January 5, 2019 (已过期)

基金规模

Up to 400,000 USD

联系方式

Zahir,Nastaran nas.zahir@nih.gov

申请资格

Commercial Organizations, Local or State Governments, Non-profit Organizations, Small and Medium Businesses, Academic Institutions

基金编号

PAR-19-113

说明

This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

网站

https://www.grants.gov/web/grants/view-opportunity.html?oppId=311317

基金资源
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接